Journal profile
Current Controlled Trials in Cardiovascular Medicine
ISSN 1468-6708 · eISSN 1468-6694 · BMC · United Kingdom
Current Controlled Trials in Cardiovascular Medicine: fully open access; APC about USD 2,890; review about 10 weeks (community reports); 0 articles in 2025.
Scope
Aims, scope and focus
Current Controlled Trials in Cardiovascular Medicine is published by BMC. By OpenAlex counts of its recent articles, its largest topics are Acute Myocardial Infarction Research, Lipoproteins and Cardiovascular Health and Coronary Interventions and Diagnostics, together about 24.5% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Trials encompasses all aspects of the performance and findings of randomized controlled trials in human health. We publish articles on general trial methodology and research into trial processes, as well as study protocols and statistical analysis plans for randomised controlled trials, commentaries and traditional results papers - regardless of outcome or significance of findings. Our aim is to promote transparency in the reporting of randomised trials and build an evidence base that will help inform the design and reporting of future trials. Within this remit, we consider articles or study protocols assessing aspects of the design, conduct or reporting of trials, as well as assessment and evaluation of lessons learnt from past trials, including those that were prematurely ended. We advocate for the collective success for trials and the importance of linking publications together (the thread of evidence). To facilitate complete and transparency reporting of research, Trials does not ask authors to adhere to strict word limits. We request that authors provide the detail required to make the research replicable. We ask that authors communicate not only all outcome measures, as well as varying analyses and interpretations, but also in-depth descriptions of what they did and what they learnt. This sharing of direct experience is fundamental to improving the quality and conduct of trials worldwide. Trials aims to experiment with, and refine, innovative approaches to improving communication about randomized controlled trials. We are keen to move beyond publishing traditional trial results articles (although these are included), and we believe this journal represents an exciting opportunity to advance the science and reporting of trials.
From the journal's Aims & Scope
Editor-in-chief Thomas BraunPublisher website
Editorial board by country: 32 in mainland China (about 11%); most named United Kingdom 84, United States 50, Mainland China 32, India 18, Canada 16 (300 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myocardial Infarction ResearchMedicine9.2%
- Lipoproteins and Cardiovascular HealthMedicine8%
- Coronary Interventions and DiagnosticsMedicine7.4%
- Cardiac Imaging and DiagnosticsMedicine7.4%
- Blood Pressure and Hypertension StudiesMedicine6.8%
- Statistical Methods in Clinical TrialsMathematics6.8%
- Cardiovascular Function and Risk FactorsMedicine4.3%
- Heart Failure Treatment and ManagementMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 23OpenAlex ·
- i10-index
- 36OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 90 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 24 |
| 2025 | 0 | 0 | 31 |
| 2024 | 0 | 0 | 47 |
| 2023 | 0 | 0 | 61 |
| 2022 | 0 | 0 | 53 |
| 2021 | 0 | 0 | 60 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Open peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,490 / USD 2,890 / GBP 2,190 | Yes | CC BY | |
| OpenAlex | GBP 1,370 | — | — | |
| LetPub | GBP 1,370 | Yes | — | |
| Publisher website | GBP 2,190 / USD 2,890 / EUR 2,490 / GBP 1,205 / USD 1,735 / EUR 1,420 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Article types accepted7
- commentResearch Methodology Review Study protocol Comment Editorial UpdateLength not stated
- editorialResearch Methodology Review Study protocol Comment Editorial UpdateLength not stated
- methodology reviewResearch Methodology Review Study protocol Comment Editorial UpdateLength not stated
- researchResearch Methodology Review Study protocol Comment Editorial UpdateLength not stated
- reviewResearch Methodology Review Study protocol Comment Editorial UpdateLength not stated
- study protocolResearch Methodology Review Study protocol Comment Editorial UpdateLength not stated
- updateResearch Methodology Review Study protocol Comment Editorial UpdateLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review, Plagiarism
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Trials articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non-Commercial N…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·- Plagiarism
Editorial policies are hosted on the BioMed Central website. Model summary
Visit the BioMed Central website to read our full editorial policies.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMC
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1468-6708
- Electronic ISSN
- 1468-6694
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Current Controlled Trials in Cardiovascular Medicine
How long does peer review take at Current Controlled Trials in Cardiovascular Medicine?
Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Current Controlled Trials in Cardiovascular Medicine based?
Of the 300 board members whose country the journal's board page names, 32 (about 11%) are in mainland China; the countries named most often are United Kingdom (84), United States (50) and Mainland China (32). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Controlled Trials in Cardiovascular Medicine?
According to LetPub and DOAJ records, Current Controlled Trials in Cardiovascular Medicine is indexed in DOAJ.
Is Current Controlled Trials in Cardiovascular Medicine open access, and what is the APC?
Current Controlled Trials in Cardiovascular Medicine is a fully open-access journal. APC about USD 2,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .